Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-21T00:35:40.508Z Has data issue: false hasContentIssue false
  • English
  • Français

Sudden hearing loss and coronavirus disease 2019: the role of corticosteroid intra-tympanic injection in hearing improvement

Part of: JLO Coronavirus Collection

Published online by Cambridge University Press:  29 April 2021

V Rahimi ,
M K Asiyabar  and
N Rouhbakhsh
V Rahimi
Affiliation:
Department of Audiology, School of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran
M K Asiyabar*
Affiliation:
ENT and Head & Neck Research center and Department, Hazrate Rasoul Hospital, The Five Senses Health Institute, Iran University of Medical Sciences, Tehran, Iran
N Rouhbakhsh
Affiliation:
Department of Audiology, School of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran
*
Author for correspondence: Dr Mojgan Kiyani Asiyabar, ENT and Head & Neck Research center and Department, Hazrate Rasoul Hospital, The Five Senses Health Institute, Iran University of Medical Sciences, Niayesh St, Sattarkhan Ave, Tehran14455-364, Iran E-mail: kiyani.asiyabar.m@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Coronavirus disease 2019 was first seen in December 2019. Due to the insidious and complex nature of the disease, the list of symptoms is rapidly expanding. So far, few studies have reported sudden sensorineural hearing loss as a possible symptom of coronavirus disease 2019.

Case report

A 60-year-old woman with a complaint of sudden sensorineural hearing loss and subjective severe tinnitus presented to the ENT clinic. Coronavirus disease 2019 was subsequently confirmed with a polymerase chain reaction test. At the time of presentation, she was treated with intra-tympanic dexamethasone. Improvements in hearing threshold and speech perception, and a subjective reduction in tinnitus, were observed after treatment.

Conclusion

This case report supports evidence from other case reports of a possible association between coronavirus disease 2019 and sudden sensorineural hearing loss. Sudden sensorineural hearing loss may be a symptom of this disease that behaves as an underlying aggravating factor. Intra-tympanic injection of corticosteroids is recommended for managing these patients during the pandemic.

Keywords

COVID-19CoronavirusSensorineural Hearing LossCorticosteroid
Type
Clinical Records
Information
The Journal of Laryngology & Otology , Volume 135 , Issue 5 , May 2021 , pp. 464 - 466
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Dr M K Asiyabar takes responsibility for the integrity of the content of the paper

References

Huang, C, Wang, Y, Li, X, Ren, L, Zhao, J, Hu, Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506CrossRefGoogle ScholarPubMed
Xu, Z, Shi, L, Wang, Y, Zhang, J, Huang, L, Zhang, C et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8:420–2CrossRefGoogle ScholarPubMed
Cao, X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol 2020;20:269–70CrossRefGoogle ScholarPubMed
Li, LQ, Huang, T, Wang, YQ, Wang, ZP, Liang, Y, Huang, TB et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol 2020;92:577–83CrossRefGoogle ScholarPubMed
Kilic, O, Kalcioglu, M, Cag, Y, Tuysuz, O, Pektas, E, Caskurlu, H et al. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss. Int J Infect Dis 2020;97:208–11CrossRefGoogle ScholarPubMed
Herman, P, Vincent, C, Parietti Winkler, C, Loundon, N, Couloigner, V, Tankere, F et al. Consensus statement. Corticosteroid therapy in ENT in the context of the COVID-19 pandemic. Eur Ann Otorhinolaryngol Head Neck Dis 2020;137:315–17CrossRefGoogle ScholarPubMed
Leung, MA, Flaherty, A, Zhang, JA, Hara, J, Barber, W, Burgess, L. Sudden sensorineural hearing loss: primary care update. Hawaii J Med Public Health 2016;75:172–4Google ScholarPubMed
Harenberg, J, Jonas, JB, Trecca, EMC. A liaison between sudden sensorineural hearing loss and SARS-CoV-2 infection. Thromb Haemost 2020;120:1237–9Google ScholarPubMed
Mustafa, MWM. Audiological profile of asymptomatic COVID-19 PCR-positive cases. Am J Otolaryngol 2020;41:102483CrossRefGoogle ScholarPubMed
Degen, C, Lenarz, T, Willenborg, K. Acute profound sensorineural hearing loss after COVID-19 pneumonia. Mayo Clin Proc 2020;95:1801–3CrossRefGoogle ScholarPubMed
Prayuenyong, P, Kasbekar, AV, Baguley, DM. Clinical implications of chloroquine and hydroxychloroquine ototoxicity for COVID-19 treatment: a mini-review. Front Public Health 2020;29:252CrossRefGoogle Scholar
Karimi-Galougahi, M, Naeini, AS, Raad, N, Mikaniki, N, Ghorbani, J. Vertigo and hearing loss during the COVID-19 pandemic - is there an association? Acta Otorhinolaryngol Ital 2020;40:463–5CrossRefGoogle ScholarPubMed
Abdel Rhman, S, Abdel Wahid, A. COVID-19 and sudden sensorineural hearing loss, a case report. Otolaryngology Case Reports 2020;16:100198CrossRefGoogle Scholar
Lang, B, Hintze, J, Conlon, B. Coronavirus disease 2019 and sudden sensorineural hearing loss. J Laryngol 2020;134:1026–8CrossRefGoogle Scholar
Koumpa, FS, Forde, CT, Manjaly, JG. Sudden irreversible hearing loss post COVID-19. BMJ Case Rep 2020;13:e238419CrossRefGoogle ScholarPubMed
Russell, C, Millar, J, Baillie, J. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020;395:473–5CrossRefGoogle Scholar
Mahase, E. COVID-19: low dose steroid cuts death in ventilated patients by one third, trial finds. BMJ 2020;369:m2422CrossRefGoogle ScholarPubMed